• News
  • Indexes
  • Events
  • Trends
  • Companies
  • Jobs
  • Strains
  1. Main
  2. Cannabis news

Cannabis news

  • Cannabis news
  • Cannabis Blog
  • Press Releases

EastWest Bioscience Ships Its New Line of Delicious Hemp and Fruit Snack Bars under Its growing Earth's Menu Brand

Houston, Pot Stock Namaste Technologies Has a Problem

GSRX Industries Inc. Announces Strong 1st Quarter Sales at the Company’s Six Dispensaries in Puerto Rico and California

Report: Exploring Fundamental Drivers Behind Roku, AECOM, 1-800 FLOWERS.COM, Eldorado Resorts, Haverty Furniture Companies, and Adamas Pharmaceuticals — New Horizons, Emerging Trends, and Upcoming Developments

Church & Dwight Stock Received Multiple Upgrades

REPEAT - Wayland Group Receives EU-GMP Certification for German Facility

GGB Beauty LLC Signs a Long Term Licensing Partnership with Authentic Brands Group and Greg Norman

Tenet Extends Collaboration with Cerner

Q1 Results Fuel Expansion in the Cannabis Sector; Where’s Weed Going Now?

GGB Beauty LLC Signs a Long Term Licensing Partnership with Authentic Brands Group and Greg Norman

Recent Analysis Shows Alexion Pharmaceuticals, Plug Power, Rayonier Advanced Materials, SunCoke Energy, Rhythm Pharmaceuticals, and Armstrong Flooring Market Influences — Renewed Outlook, Key Drivers of Growth

Cronos stock downgraded after rocketing more than 100% in 2019 so far

Consolidated Research: 2019 Summary Expectations for Cronos Group, Constellation Brands, Eagle Materials, Itron, The Hanover Insurance Group, and Scholastic — Fundamental Analysis, Key Performance Indications

Meridian Launches New Range of Lyo-Ready PCR Mixes

MedMen Announces Completion of Real Estate Sale to Cannabis REIT

Planet 13 Supports the Creation of Cannabis Compliance Board to Oversee the Nevada Cannabis Industry

Emerging markets to fuel Smith & Nephew revenue growth in 2019

UPDATE 1-Emerging markets to fuel Smith & Nephew revenue growth in 2019

Smith & Nephew misses on Q4 revenue as developed markets slow

Wayland Group Receives EU-GMP Certification for German Facility

INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Liberty Health Sciences Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against 22nd Century Group, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm

ePlus Inc (PLUS) Q3 2019 Earnings Conference Call Transcript

Cannabis Grower Aphria Rejects Green Growth’s Hostile Offer

EPlus (PLUS) Beats Q3 Earnings and Revenue Estimates

Green Growth Brands Comments on Offer for Aphria Inc.

What Are Analysts Recommending for Curaleaf Holdings?

CLASS ACTION ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Significant Losses From Investment In Liberty Health Sciences, Inc. (Other OTC: LHSIF) To Contact Brower Piven Before The Lead Plaintiff Deadline

Helix TCS Buys Blockchain-Enabled Cannabis Trading Platform Operator Amercanex International Exchange

We Just Had One of the Choppiest Days of Action So Far This Year

Why Electronic Arts, Aphria, and Anadarko Petroleum Slumped Today

Aphria Tumbles After Rejecting Hostile Takeover Bid From Green Growth Brands

A Look at Curaleaf’s Core Operations and Expansion Plans

  • <
  • 1
  • …
  • 250
  • 251
  • 252
  • 253
  • 254
  • 255
  • 256
  • …
  • 297
  • >
Connect with
us on Social
[email protected]
Join our newsletter
GO
 
Email: [email protected]
News Indexes Events Trends Companies Jobs Strains Advertise
Infuzes.com is the largest cannabis industry database with company profiles, an integrated smart tracker, and global analytics as a resource for cannabis professionals offering essential insights, also giving institutional and retail investors access to real-time, high-quality, reliable market and pricing data.
logo
Privacy policy, Sitemap.
© 2025 | infuzes.com – Made for the Cannabis Industry.
Loading...
 
Get the Freshest Infuzes
Subscribe to our newsletter
Subscribe
Welcome to Infuzes.
Thanks for stopping by.
Are you at least 21? Darn! You're not old enough to use Infuzes.
By accessing this site, you accept the Terms of use and Privacy policy.